Our Peak says skin can lag behind when people lose a lot of weight quickly on GLP-1 drugs, since it needs time to remodel.
Recap by typeshit. Post by @our_peak on Instagram.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
The hospital says tirzepatide may help with weight when medically appropriate but calls it no shortcut, urging people to understand the risks first.
More reports are surfacing of off-target effects from obesity drugs, alongside a push at HHS to move drug development faster.
Loading…